Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of Weight-Adjusted Caffeine and β-Blocker Use With Ophthalmology Fellow Performance During Simulated Vitreoretinal Microsurgery.
Roizenblatt M, Dias Gomes Barrios Marin V, Grupenmacher AT, Muralha F, Faber J, Jiramongkolchai K, Gehlbach PL, Farah ME, Belfort R Jr, Maia M. Roizenblatt M, et al. Among authors: grupenmacher at. JAMA Ophthalmol. 2020 Aug 1;138(8):819-825. doi: 10.1001/jamaophthalmol.2020.1971. JAMA Ophthalmol. 2020. PMID: 32525517 Free PMC article. Clinical Trial.
Biocompatibility of polyvinyl alcohol/trisodium trimetaphosphate as vitreous substitute in experimental vitrectomy model in rabbits.
de Oliveira RA, Muralha FP, Grupenmacher AT, de Araújo Morandim-Giannetti A, Bersanetti PA, Maia M, Magalhães Junior O. de Oliveira RA, et al. Among authors: grupenmacher at. J Biomed Mater Res B Appl Biomater. 2022 Feb;110(2):460-466. doi: 10.1002/jbm.b.34923. Epub 2021 Jul 29. J Biomed Mater Res B Appl Biomater. 2022. PMID: 34328263
Reply to Comment on: Long-term Results of Trimethoprim Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis.
Fernandes Felix JP, Cavalcanti Lira RP, Grupenmacher AT, de Assis Filho HLG, Cosimo AB, Nascimento MA, Leite Arieta CE. Fernandes Felix JP, et al. Among authors: grupenmacher at. Am J Ophthalmol. 2020 Dec;220:217-218. doi: 10.1016/j.ajo.2020.08.008. Epub 2020 Oct 21. Am J Ophthalmol. 2020. PMID: 33097174 No abstract available.
New anti-angiogenic compound based on chemically modified heparin.
Kniggendorf V, Souza MEP, Russo T, de Lima MA, Grupenmacher AT, Regatieri CV, Dreyfuss JL. Kniggendorf V, et al. Among authors: grupenmacher at. Graefes Arch Clin Exp Ophthalmol. 2022 Dec;260(12):3847-3855. doi: 10.1007/s00417-022-05828-x. Epub 2022 Sep 13. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 36097187
Ocular Manifestations and Neuropathy in Type 2 Diabetes Patients With Charcot Arthropathy.
Trindade M, Castro de Vasconcelos J, Ayub G, Grupenmacher AT, Gomes Huarachi DR, Viturino M, Correa-Giannella ML, Atala YB, Zantut-Wittmann DE, Parisi MC, Alves M. Trindade M, et al. Among authors: grupenmacher at. Front Endocrinol (Lausanne). 2021 Apr 21;12:585823. doi: 10.3389/fendo.2021.585823. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33967949 Free PMC article.